Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NOK vs GSK✓SelectedUSD · GSKNOK vs GSK performance historyLatest closeAs of-2.54%11/13
Stock and ETF performance explorer

NOK vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+147.0%
GSK return
+65.8%
Excess return
+81.2%
Maximum drawdown
-55.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.5%+0.5%-3.1%-2.5%
7D+5.4%+1.1%+4.2%+5.3%
30D-14.1%+6.3%-20.5%-14.3%
3M-23.6%+1.8%-25.4%-23.5%
6M-45.1%+1.7%-46.8%-45.3%
YTD+24.7%+6.5%+18.2%+23.3%
1Y+19.0%+9.5%+9.5%+17.0%
3Y+147.0%+65.3%+81.7%+129.0%
All+147.0%+65.8%+81.2%+129.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling